K. Mrózek

发表

Clinical significance of cytogenetics in acute myeloid leukemia.

C. Bloomfield, A. de la Chapelle, K. Mrózek, 1997, Seminars in oncology.

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia

M. Caligiuri, C. Bloomfield, J. Byrd, 2013, Leukemia.

Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.

C. Bloomfield, L. Blumenson, K. Mrózek, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.

C. Bloomfield, J. Fay, Y. Rustum, 1996, Blood.

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

Karl W. Kroll, C. Bloomfield, J. Byrd, 2017, Leukemia.

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Karl W. Kroll, C. Bloomfield, J. Byrd, 2017, Leukemia.

Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.

C. Bloomfield, C. Karakousis, K. Mrózek, 1993, Cancer research.

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.

M. Caligiuri, C. Bloomfield, C. Croce, 1996, Cancer research.

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).

C. Bloomfield, C. Schiffer, R. Larson, 2001, Blood.

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

R M Stone, S L George, M. Caligiuri, 2011, Leukemia.

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.

M. Caligiuri, C. Bloomfield, C. Croce, 1994, Cancer research.

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

M. Caligiuri, C. Bloomfield, K. Metzeler, 2013, Leukemia.

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8

M. Caligiuri, M. Radmacher, K. Metzeler, 2014, Leukemia.

High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.

C. Bloomfield, K. Mrózek, M. Baer, 1993, Seminars in oncology.

New recurrent structural chromosome aberrations in non-Hodgkin's lymphoma.

C. Bloomfield, K. Mrózek, 1996, International journal of oncology.

Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Karl W. Kroll, C. Bloomfield, J. Byrd, 2016, Leukemia.

Cytogenetics of indolent lymphomas.

C. Bloomfield, K. Mrózek, 1993, Seminars in Oncology.

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

C. Bloomfield, J. Byrd, S. Volinia, 2016, Leukemia.